Balyasny Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-137,057
| Closed | -$3.99M | – | 2350 |
|
|
2024
Q4 | $3.99M | Sell |
137,057
-23,752
| -15% | -$691K | 0.01% | 917 |
|
|
2024
Q3 | $7.39M | Buy |
+160,809
| New | +$7.39M | 0.01% | 753 |
|
|
2024
Q2 | – | Sell |
-51,055
| Closed | -$1.3M | – | 2341 |
|
|
2024
Q1 | $1.3M | Sell |
51,055
-1,164,782
| -96% | -$29.7M | ﹤0.01% | 1193 |
|
|
2023
Q4 | $11M | Sell |
1,215,837
-804,053
| -40% | -$7.28M | 0.02% | 607 |
|
|
2023
Q3 | $12.9M | Buy |
2,019,890
+27,056
| +1% | +$173K | 0.03% | 552 |
|
|
2023
Q2 | $22.1M | Buy |
1,992,834
+1,370,920
| +220% | +$15.2M | 0.05% | 403 |
|
|
2023
Q1 | $9.55M | Sell |
621,914
-26,912
| -4% | -$413K | 0.02% | 615 |
|
|
2022
Q4 | $14.4M | Buy |
648,826
+591,619
| +1,034% | +$13.1M | 0.04% | 491 |
|
|
2022
Q3 | $934K | Sell |
57,207
-129,495
| -69% | -$2.11M | ﹤0.01% | 1414 |
|
|
2022
Q2 | $2.71M | Buy |
+186,702
| New | +$2.71M | 0.01% | 1006 |
|
|
2021
Q3 | – | Sell |
-156,047
| Closed | -$3.86M | – | 2027 |
|
|
2021
Q2 | $3.86M | Buy |
+156,047
| New | +$3.86M | 0.02% | 711 |
|